When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Последний просмотренный: 22 Oct 2026
Last updated: 22 Jul 2026
22 Jul 2026

WHO declares cruise ship outbreak over

​The World Health Organization (WHO) has declared that the hantavirus outbreak linked to the M/V Hondius cruise ship is over. All identified contacts of cases completed a 42-day follow-up period on 2 July 2026, with no secondary cases detected among contacts.

A total of 13 cases, including 3 deaths, were reported during the outbreak, with a case fatality rate of 23%. Males accounted for 69% of cases, and the average age was 65 years. All confirmed cases were among people who traveled onboard the ship, although some people became symptomatic after disembarkation.

The Dutch-flagged cruise ship departed Argentina on 1 April 2026 carrying 147 passengers and crew, and traveled across the South Atlantic with various stops in remote regions. ​The outbreak was first reported to the WHO on 2 May 2026.

The outbreak was caused by the Andes virus (ANDV), a species of hantavirus typically found in South America. It is the only species that has been associated with limited human-to-human transmission, particularly in community settings involving close and prolonged contact, and among healthcare professionals looking after infected patients.

Initial cases likely acquired the infection on land before embarkation (the exact source is currently unknown), with subsequent human-to-human transmission on board the ship. Investigations into the source of the outbreak continue.

Смотрите Эпидемиология

Оригинальный источник обновления

Резюме

Определение

Анамнез и осмотр

Другие диагностические факторы

  • fever
  • myalgia
  • gastrointestinal symptoms
  • headache
  • normal or low oxygen saturation
  • lung rales
  • cough, chest tightness

Факторы риска

  • exposure to rodent excreta/bite
  • close contact with hantavirus-infected humans

Диагностические исследования

Алгоритм лечения

Составители

Авторы

Michael Sands, MD, MPH &TM, FIDSA
Michael Sands

Professor of Medicine

College of Medicine

University of Florida

Jacksonville, FL

Раскрытие информации

MS declares that he has no competing interests.

Carmen Isache, MD
Carmen Isache

Professor of Medicine

College of Medicine

University of Florida

Jacksonville, FL

Раскрытие информации

CI declares that she has no competing interests.

Рецензенты

Tze Wai Wong, FFPH, FRCP (Glasg)

Professor

School of Public Health and Primary Care

The Chinese University of Hong Kong

Prince of Wales Hospital

Shatin

Hong Kong

Раскрытие информации

TWW declares that he has no competing interests.

Mary Joung Won Choi, MD, MPH

Medical Officer

Viral Special Pathogens Branch

US Centers for Disease Control and Prevention

Atlanta, GA

Раскрытие информации

MC declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Centres for Disease Control and Prevention. ​Clinician brief: hantavirus pulmonary syndrome (HPS). May 2026 [internet publication].Полный текст

Ulloa-Morrison R, Pavez N, Parra E, et al. Critical care management of hantavirus cardiopulmonary syndrome. A narrative review. J Crit Care. 2024 Dec;84:154867.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available here.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности